G. Pauli (Strasbourg, France), A. G. Chuchalin (Moscow, Russia)
Patient centred evaluation, using montelukast in clinical practice
S. Dermott, R. J. Wolstenholme (Wigan, United Kingdom)
|  |
No interaction of roflumilast, a new, orally active, selective PDE4 inhibitor, with inhaled salbutamol
C. Weimar, K. Westphal, T. Bethke, M. David, K. Zech, W. Siegmund, W. Wurst (Konstanz, Greifswald, Germany)
| |
Roflumilast, a new, orally active, selective PDE4 inhibitor, does not interact with inhaled budesonide
T. Bethke, K. Westphal, C. Weimar, M. David, K. Zech, W. Siegmund, W. Wurst (Konstanz, Greifswald)
| |
Smoking has no effect on the pharmacokinetics of roflumilast, a new, orally active, selective PDE4 inhibitor
T. Bethke, A. Hünnemeyer, B. Hauns, A. Diedrich, A. Baumgartner, C. Eichberger, A. Drollmann, M. Hartmann, M. Neuhäuser, M. David, K. Zech, W. Wurst (Konstanz, Germany)
| |
Long-term treatment of aspirin-intolerante asthma with budesonide. Effectivity and safety
O. A. Soutotchnikova, A. V. Cherniak, A. G. Chuchalin (Moscow, Russia)
| |
A study to evaluate the therapeutic equivalence of a new multidose budesonide dry powder inhaler with a conventional budesonide dry powder inhaler
F. B. Naber, A. K. Hall (Heemskerk, Leiderdorp, The Netherlands)
| |
Secondary osteoporosis in patients with bronchial asthma
I. Baranova, K. Gadjiev, N. Toroptsova, N. Dyemin, N. Kniajeskaya, L. Benevolenskaya, A. Chuchalin (Moscow, Russia)
| |
Cost-effectiveness of budesonide and formoterol in a single inhaler compared to fluticasone in the treatment of asthma
K. Ericsson, T. A. Bantje, R. Huber, S. Borg, F. Andersson (Lund, Sweden; Breda, The Netherlands; Munich, Germany)
| |
Early and sustained benefits of budesonide and formoterol in a single inhaler vs fluticasone in moderate asthma
E. D. Bateman, T. A. Bantje, M. Joao Gomes, M. Toumbis, R. Huber, A. Eliraz (Cape Town, South Africa; Breda, The Netherlands; Lisbon, Portugal; Athens, Greece; Munich, Germany; Rehovot, Israel)
| |
Fracture risk in perimenopausal asthmatic women
A. K. Laatikainen, H. P. J. Kroger, H. O. Tukiainen, R. J. Honkanen, S. V. Saarikoski (Kuopio, Finland)
| |
Flutide™ Diskus™ less consistent than Pulmicort® Turbuhaler® with respect to in vitro fine particle dose proportionality
L. Asking, T. Lööf, G. Pettersson (Lund, Sweden)
| |
A study to examine the prevalence of osteoporosis and osteopenia in patients attending a difficult asthma clinic
F. M. Crummy, J. Gamble, J. Leggett, H. Taggart, L. G. Heaney (Belfast, Craigavon, United Kingdom)
| |
Same minimal effective dose of budesonide Turbuhaler® and fluticasone Diskus®/Accuhaler® in adult asthmatics
P. Kuna, H. Magnussen, J. Joubert, A. P. M. Greefhorst (Lodz, Poland; Stellenbosch, Germany; Stellenbosch, South Africa; Midden-Twente, The Netherlands)
| |
Low-dose single-inhaler budesonide/formoterol administered once daily is effective in mild-persistent asthma
P. Kuna, A. Chuchalin, N. Ringdal, E. A. De la Padilla, P. Black, A. Lindqvist, U. Nihlen, C. Vogelmeier (Lodz, Poland; Moscow, Russia; Molde, Norway; Jalisco, Mexico; Auckland, New Zealand; Helsinki, Finland; Lund, Sweden; Marburg, Germany)
| |
Reversible intracellular esterification increases budesonide airway selectivity
H. Falk Nilsson, P. Strandberg, R. Brattsand, A. Miller-Larsson (Lund, Sweden)
| |
Higher cellular retention and activity after pulse exposure by budesonide (BUD) than fluticasone propionate (FP) and mometasone furoate (MF)
A. Jerre, E. Wieslander, A. Miller-Larsson, R. Brattsand (Lund, Sweden)
| |
Budesonide and formoterol in a single inhaler is more effective than a higher dose of inhaled corticosteroid in mild-moderate persistent asthma
U. G. Lalloo, J. Malolepszy, D. Kozma, K. Krofta, J. Ankerst, B. Johansen, N. C. Thomson (Durban, South Africa; Wroclaw, Poland; Budapest, Hungary; Prague, Czech Republic; Lund, Sweden)
| |
The cost-effectiveness of achieving asthma control with the combination products salmeterol/fluticasone propionate or formoterol/budesonide
M. J. Price, A. H. Briggs (Greenford, Oxford, United Kingdom)
| |
Budesonide and formoterol in a single inhaler is safe and effective in the treatment of asthma
L. Rosenhall, J. H. Heinig, A. Lindqvist, J. Leegard, P. B. F. Bergqvist (Stockholm, Lund, Sweden; Copenhagen, Denmark; Helsinki, Finland; Farsund, Norway)
| |